Pregnancy: Category C.
The potential risk for humans is unknown. Caution should be exercised when prescribing to pregnant women. Lactation: The use of Solifenacin should be avoided during breast-feeding.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education